Iron deficiency is the most common nutritional disorder affecting pregnant women worldwide, often leading to maternal anemia and adverse fetal outcomes. Traditional markers, such as hemoglobin concentration, frequently detect deficiency only after significant hematologic changes have occurred. Osmotic fragility (OF), a measure of red blood cell membrane stability, provides insight into early erythrocyte dysfunction. This review examines differences in OF profiles between iron-deficient and iron-replete pregnant women, highlighting its potential as an early biomarker for subclinical iron deficiency. Evidence indicates that iron-deficient pregnancies exhibit elevated OF, reflecting compromised red blood cell integrity, increased hemolysis risk, and potential maternal and fetal complications. Understanding these dynamics supports the integration of OF testing into prenatal care, enabling timely interventions and improving maternal-fetal outcomes.

Pregnancy is a period of profound physiological, metabolic, and hematologic adaptation, designed to support fetal growth and maternal well-being. Among the most significant changes is the expansion of plasma volume, which increases by approximately 40–50% by the third trimester, accompanied by enhanced erythropoiesis to meet elevated oxygen demands [1-2]. While these adaptations are essential, they also place pregnant women at increased risk of nutritional deficiencies, particularly iron deficiency, which is the most common micronutrient deficiency worldwide. Globally, an estimated 38% of pregnant women suffer from anemia, with iron deficiency accounting for the majority of cases. In low- and middle-income countries, prevalence rates are even higher due to inadequate dietary intake, parasitic infections, and limited access to supplementation [3-4]. Iron deficiency during pregnancy has far-reaching consequences. Maternal outcomes include fatigue, decreased cognitive function, increased susceptibility to infections, and impaired work capacity. Fetal consequences may include intrauterine growth restriction, preterm birth, low birth weight, and long-term neurodevelopmental impairment. Despite the serious implications, early detection of iron deficiency remains challenging because traditional hematologic indices such as hemoglobin concentration and hematocrit often detect deficiency only after significant anemia has developed. This delay limits opportunities for early intervention and prevention of adverse outcomes [5-7].

Red blood cells (RBCs) are highly specialized, flexible cells responsible for oxygen transport. Their integrity depends on a complex interplay between hemoglobin content, membrane lipid composition, and cytoskeletal protein structure. Disruptions in these components, as seen in iron deficiency, compromise RBC stability and function. Osmotic fragility (OF), defined as the susceptibility of RBCs to hemolysis in hypotonic solutions, provides a functional measure of RBC membrane integrity. Changes in OF can occur before measurable declines in hemoglobin or hematocrit, offering a potential early indicator of subclinical iron deficiency [8-9]. Previous studies have shown that pregnant women with iron deficiency exhibit higher osmotic fragility compared to iron-replete counterparts, reflecting compromised erythrocyte resilience. This early erythrocyte stress may have important clinical and public health implications, enabling timely interventions that prevent the progression to anemia and reduce maternal and fetal complications. Moreover, osmotic fragility testing is relatively simple, low-cost, and could be adapted for resource-limited settings where anemia prevalence is high and laboratory infrastructure may be limited [10-12]. This review examines the physiological basis of osmotic fragility in pregnancy, explores trimester-specific dynamics, and compares profiles between iron-deficient and iron-replete pregnant women. It further evaluates the potential of osmotic fragility as an early biomarker for detecting subclinical iron deficiency, highlighting its implications for clinical practice and public health interventions. By understanding these dynamics, clinicians and researchers can better identify at-risk women, implement timely nutritional interventions, and optimize maternal and fetal outcomes.

Physiological Basis of Osmotic Fragility in Pregnancy

Red blood cells (RBCs) are highly specialized, flexible cells designed to transport oxygen efficiently throughout the body. Their unique biconcave shape, combined with a lipid-rich membrane supported by a cytoskeletal network of proteins, allows them to withstand mechanical and osmotic stress as they traverse the circulatory system. Osmotic fragility (OF) refers to the susceptibility of RBCs to hemolysis when exposed to hypotonic solutions—a reflection of the structural integrity and stability of the cell membrane [13-14]. During pregnancy, profound hematologic and metabolic adaptations occur. Plasma volume increases by approximately 40–50%, causing a relative hemodilution that can mask early iron deficiency. Simultaneously, erythropoietic activity rises to meet the oxygen demands of the developing fetus, leading to increased production of RBCs. These physiologic changes, while essential, place additional stress on erythrocytes [15-16]. Iron plays a critical role in hemoglobin synthesis and RBC maturation. In iron-replete pregnancies, RBC membranes maintain their elasticity and resilience, ensuring normal osmotic tolerance. In contrast, iron deficiency disrupts hemoglobin production and alters membrane composition, rendering RBCs more fragile and susceptible to premature lysis. Oxidative stress, common in pregnancy, further weakens RBC membranes, particularly in iron-deficient women. Consequently, osmotic fragility increases, reflecting both impaired erythrocyte function and early hematologic stress [17-18].

Trimester-Specific Osmotic Fragility Dynamics

Pregnancy is characterized by progressive hematologic adaptations across trimesters, which influence red blood cell (RBC) properties, including osmotic fragility (OF). Understanding these trimester-specific changes is critical for interpreting OF profiles and detecting early iron deficiency (Table 1).

First Trimester: In early pregnancy, plasma volume expansion begins gradually, and erythropoiesis is just starting to adapt to increased oxygen demands. Red blood cells generally maintain their structural integrity, and osmotic fragility remains relatively stable in healthy, iron-replete women. However, subtle increases in OF may occur in iron-deficient women, reflecting early membrane instability before conventional hematological markers indicate anemia. These early alterations may serve as a warning signal for impending hematologic stress [19-20].

Second Trimester: The second trimester is marked by rapid plasma volume expansion and a peak in iron demand due to increased fetal growth. In iron-replete pregnancies, RBCs accommodate these changes with minimal disruption in membrane stability. Conversely, iron-deficient women may show a noticeable rise in osmotic fragility, as newly produced erythrocytes are more vulnerable to lysis under hypotonic stress. This period represents a critical window for detecting subclinical iron deficiency and initiating timely supplementation [21-22].

Third Trimester: By the third trimester, plasma volume has peaked, and erythropoietic activity continues at a high rate. In iron-deficient women, cumulative effects of inadequate iron supply, oxidative stress, and membrane lipid alterations often manifest as markedly elevated osmotic fragility. Clinically, this corresponds to an increased risk of anemia, hemolysis, and associated maternal and fetal complications. Iron-replete women, however, typically maintain stable OF profiles, highlighting the protective effect of adequate iron stores [23-24].

Table 1: Trimester-Specific Osmotic Fragility Dynamics in Pregnancy.

Osmotic Fragility in Iron-Deficient versus Iron-Replete Pregnant Women

Red blood cell (RBC) osmotic fragility reflects the structural integrity and functional resilience of erythrocytes under hypotonic stress. In pregnancy, osmotic fragility is influenced by physiological hemodilution, increased erythropoiesis, and nutritional status—particularly iron availability. Comparing iron-deficient and iron-replete pregnant women provides important insights into early hematologic changes that precede overt anemia (Table 2).

Iron-Replete Pregnancies: Women with adequate iron stores generally maintain stable RBC membranes throughout gestation. Their erythrocytes exhibit normal osmotic fragility, demonstrating resistance to hypotonic lysis despite the physiological stresses of pregnancy. Hemoglobin synthesis, membrane lipid composition, and cytoskeletal protein integrity remain largely intact, supporting normal RBC deformability and longevity [25-26].

Iron-Deficient Pregnancies: In contrast, iron deficiency disrupts hemoglobin synthesis and alters membrane composition, increasing RBC susceptibility to osmotic stress. Studies consistently show that iron-deficient pregnant women exhibit elevated osmotic fragility compared to their iron-replete counterparts. These changes often appear before hemoglobin concentrations fall below clinical thresholds, highlighting the sensitivity of OF as an early indicator of subclinical iron deficiency. The elevated OF in iron-deficient pregnancies correlates with microcytosis, hypochromia, and increased risk of hemolysis, which can compromise oxygen delivery to maternal and fetal tissues [27-28].

Clinical Implications: The differential OF profiles between iron-deficient and iron-replete women underscore its potential as a biomarker for early detection. Unlike conventional hematologic indices, which reflect later stages of deficiency, osmotic fragility captures functional alterations in RBCs at a pre-anemic stage. This early warning can guide timely iron supplementation and monitoring, reducing the risk of maternal anemia and adverse fetal outcomes [29].

Table 2: Osmotic Fragility in Iron-Deficient versus Iron-Replete Pregnant Women.

Clinical Implications and Biomarker Potential

The differences in osmotic fragility (OF) between iron-deficient and iron-replete pregnant women carry significant clinical implications. Elevated OF in iron-deficient pregnancies reflects compromised red blood cell (RBC) membrane integrity, which can precede overt anemia. Detecting these early changes offers a unique opportunity to intervene before maternal hemoglobin levels decline to clinically significant thresholds, potentially preventing complications such as fatigue, impaired immunity, preterm delivery, and low birth weight [30-31]. From a diagnostic perspective, OF testing provides a functional assessment of erythrocytes, complementing conventional biochemical markers like hemoglobin, hematocrit, and serum ferritin. Unlike static measures, OF captures subtle membrane instability and erythrocyte vulnerability under osmotic stress, making it a sensitive early indicator of iron deficiency. When integrated into routine prenatal care, OF profiling could serve as a predictive biomarker to identify women at risk, allowing clinicians to initiate tailored interventions, such as iron supplementation or dietary counseling, at an earlier stage [32-33].

Beyond individual patient care, OF has potential value in public health screening programs, particularly in resource-limited settings where anemia is prevalent, and conventional laboratory testing may be delayed or inaccessible. Standardized, low-cost OF assays could help prioritize high-risk pregnancies, monitor the effectiveness of supplementation programs, and track population-level improvements in maternal hematologic health [34-36]. Despite its promise, widespread clinical application of OF testing requires further validation. Establishing pregnancy-specific reference ranges, standardizing laboratory methodologies, and understanding the influence of coexisting conditions—such as hemoglobinopathies or inflammation—are essential for accurate interpretation. Additionally, combining OF with other early markers, such as reticulocyte indices or oxidative stress measures, may enhance its predictive power [37-38].

Osmotic fragility offers a valuable window into the functional health of red blood cells during pregnancy, reflecting subtle changes in membrane stability that often precede overt anemia. Iron-deficient pregnant women consistently exhibit elevated osmotic fragility compared to their iron-replete counterparts, highlighting compromised erythrocyte integrity and increased susceptibility to hemolysis. These alterations are observable across trimesters, with cumulative effects becoming most pronounced in late pregnancy, underscoring the importance of early detection. The potential of osmotic fragility as an early biomarker for iron deficiency is significant. By identifying women at risk before conventional hematological indices indicate anemia, clinicians can implement timely, targeted interventions such as iron supplementation and dietary optimization. Integrating OF assessment into prenatal care could improve maternal well-being, enhance fetal development, and reduce the burden of pregnancy-related anemia. Future research should focus on standardizing OF measurement techniques, establishing trimester-specific reference ranges, and evaluating its predictive value in diverse populations. When combined with other hematologic and biochemical indicators, osmotic fragility has the potential to become an integral tool for proactive, precision-based prenatal care.